aerosolized vaccine for measles was developed in Mexico and

Last updated: 10/15/2023

aerosolized vaccine for measles was developed in Mexico and has been used on more than 4 million children since 1980 Aerosolized vaccines have the advantages of being able to be administered by people without clinical training and do not cause injection associated infections The percentage of children developing an immune response to measles after receiving the subcutaneous injection of the vaccine is 95 and for those receiving the aero solized vaccine it is 85 There are 20 children to be vaccinated for measles using the aerosolized vaccine in a small rural village in India We are going to count the num ber who devel im oped an mune response to measles after vaccination Dr P Marazzi Science Source a Explain why this is a binomial setting b What is the probability that at least one child does not develop an immune response to measles after receiving the aerosolized vaccine What would be the probability that at least one child does not develop an immune response to measles if all children were